ATE253352T1 - Verwendung einer zusammensetzung enthaltend polyether block copolymere - Google Patents

Verwendung einer zusammensetzung enthaltend polyether block copolymere

Info

Publication number
ATE253352T1
ATE253352T1 AT96925056T AT96925056T ATE253352T1 AT E253352 T1 ATE253352 T1 AT E253352T1 AT 96925056 T AT96925056 T AT 96925056T AT 96925056 T AT96925056 T AT 96925056T AT E253352 T1 ATE253352 T1 AT E253352T1
Authority
AT
Austria
Prior art keywords
polyether block
composition containing
block copolymers
containing polyether
compositions
Prior art date
Application number
AT96925056T
Other languages
English (en)
Inventor
Alexander V Kabanov
Valery Yu Alakhov
Peter G Sveshnikov
Eugenii S Severin
Original Assignee
Supratek Pharma Inc
Alexander V Kabanov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Supratek Pharma Inc, Alexander V Kabanov filed Critical Supratek Pharma Inc
Application granted granted Critical
Publication of ATE253352T1 publication Critical patent/ATE253352T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT96925056T 1995-06-07 1996-06-07 Verwendung einer zusammensetzung enthaltend polyether block copolymere ATE253352T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/478,978 US5817321A (en) 1992-10-08 1995-06-07 Biological agent compositions
PCT/IB1996/000799 WO1996040055A2 (en) 1995-06-07 1996-06-07 Biological agent compositions

Publications (1)

Publication Number Publication Date
ATE253352T1 true ATE253352T1 (de) 2003-11-15

Family

ID=23902177

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96925056T ATE253352T1 (de) 1995-06-07 1996-06-07 Verwendung einer zusammensetzung enthaltend polyether block copolymere

Country Status (12)

Country Link
US (1) US5817321A (de)
EP (2) EP0871432B1 (de)
JP (1) JP4167299B2 (de)
CN (1) CN1192678A (de)
AT (1) ATE253352T1 (de)
AU (1) AU700021B2 (de)
BR (1) BR9609176A (de)
CA (1) CA2222776A1 (de)
DE (1) DE69630615T2 (de)
NZ (1) NZ313271A (de)
RU (1) RU2166934C2 (de)
WO (1) WO1996040055A2 (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
US6040295A (en) 1995-01-13 2000-03-21 Genemedicine, Inc. Formulated nucleic acid compositions and methods of administering the same for gene therapy
EP0832653A1 (de) * 1996-09-20 1998-04-01 Max-Delbrück-Centrum Für Molekulare Medizin Verwenddung von Cytokinen und cytotoxischen Substanzen in einem neuen Verfahren zur Tumorbehandlung
US20020115609A1 (en) * 1997-07-14 2002-08-22 Hayat Onyuksel Materials and methods for making improved micelle compositions
US20050025819A1 (en) * 1997-07-14 2005-02-03 Hayat Onyuksel Materials and methods for making improved micelle compositions
US5948896A (en) * 1997-08-13 1999-09-07 Gem Pharmaceuticals Processes for preparing 13-deoxy anthracycline derivatives
WO2000069942A1 (en) * 1999-05-19 2000-11-23 University Of Utah Research Foundation Stabilization and acoustic activation of polymeric micelles for drug delivery
US6713454B1 (en) 1999-09-13 2004-03-30 Nobex Corporation Prodrugs of etoposide and etoposide analogs
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
ATE304870T1 (de) * 1999-10-29 2005-10-15 Los Angeles Childrens Hospital Verfahren und material zur hämostase bei knochen
US9616150B2 (en) * 1999-10-29 2017-04-11 Children's Hospital Los Angeles Bone hemostasis method and materials
IL141438A0 (en) * 2000-02-23 2002-03-10 Pfizer Prod Inc Method of increasing the bioavailability and tissue penetration of azithromycin
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US7256180B2 (en) 2000-04-28 2007-08-14 Supratek Pharma Inc. Compositions and methods for inducing activation of dendritic cells
TWI249519B (en) 2000-08-29 2006-02-21 Nobex Corp Immunoregulatory compounds and derivatives and methods of treating diseases therewith
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
SE0101702D0 (sv) 2001-05-15 2001-05-15 Ardenia Investments Ltd Novel potentiating compounds
GB0120701D0 (en) * 2001-08-24 2001-10-17 Maelor Pharmaceuticals Ltd Pharmaceutical formulations
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
RU2004119557A (ru) * 2001-12-20 2005-04-20 Бристол-Маерс Сквибб Компани (Us) Фармацевтические композиции перорально активных производных таксана с повышенной биодоступностью
AU2003212888A1 (en) * 2002-02-06 2003-09-02 Combinatorx, Incorporated Combinations for the treatment of fungal infections
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
WO2004010970A1 (en) * 2002-07-29 2004-02-05 Alza Corporation Formulations and dosage forms for controlled delivery of topiramate
TWI367113B (en) 2003-02-12 2012-07-01 Syncera Inc Random and non-random alkylene oxide polymer alloy compositions
CA2533178C (en) 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005009364A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005016306A2 (en) * 2003-08-06 2005-02-24 Alza Corporation Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
WO2005016311A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
AU2004264356B2 (en) 2003-08-12 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP5686494B2 (ja) * 2003-08-29 2015-03-18 シオノギ インコーポレイテッド 抗生物質製剤、その使用法及び作成方法
EP1663169A4 (de) 2003-09-15 2010-11-24 Middlebrook Pharmaceuticals In Antibiotisches produkt, seine verwendung und formulierung
US20050112204A1 (en) * 2003-11-25 2005-05-26 Pfizer Inc. Pharmaceutical formulations
WO2005065648A2 (en) * 2003-12-29 2005-07-21 Alza Corporation, Inc., Novel drug compositions and dosage forms of topiramate
US20050175696A1 (en) * 2003-12-29 2005-08-11 David Edgren Drug granule coatings that impart smear resistance during mechanical compression
EP1701706A2 (de) * 2003-12-29 2006-09-20 Alza Corporation Neue arzneimittelzusammensetzungen und dosierformen
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
HUE028158T2 (en) 2004-07-07 2016-12-28 Biocon Ltd Synthesis of bound immunoregulatory compounds
CA2630578C (en) * 2005-11-30 2014-04-15 Generex Pharmaceuticals Inc. Orally absorbed pharmaceutical formulation and method of administration
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
AU2007204954A1 (en) * 2006-01-10 2007-07-19 Innovaform Technologies, Llc Pesticide delivery system
US8148338B2 (en) * 2006-02-22 2012-04-03 Supratek Pharma Inc. Doxorubicin formulations for anti-cancer use
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
KR20090009241A (ko) * 2006-05-18 2009-01-22 니폰 가야꾸 가부시끼가이샤 포도필로톡신류의 고분자 결합체
BRPI0603871B8 (pt) * 2006-08-24 2021-05-25 Fundacao Univ De Brasilia composições farmacêuticas para o tratamento de tripanossomíases e de doença de chagas
CA2717867C (en) 2008-03-07 2017-05-30 Paul J. Shami Activated nitric oxide donors and methods of making and using thereof
EP2265256A1 (de) * 2008-03-17 2010-12-29 University of Utah Research Foundation Dithiocarbamat-metall-chelate und verfahren zu ihrer herstellung und verwendung
MD4009C2 (ro) * 2008-07-15 2010-08-31 Институт Химии Академии Наук Молдовы Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
US8445271B2 (en) 2010-05-03 2013-05-21 Enzo Life Sciences, Inc. Processes and kits for determining multi-drug resistance of cells
RU2501570C1 (ru) * 2012-05-11 2013-12-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) федеральный университет" (ФГАОУВПО КФУ) Трехфункциональные блоксополимеры этиленоксида и пропиленоксида для доставки активных веществ в живые клетки
US10792331B2 (en) * 2015-09-09 2020-10-06 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Methods for reducing cardiotoxicity from chemotherapy by administering humanin analog compositions
CN109324512A (zh) * 2018-12-05 2019-02-12 华北电力大学 一种利用已知模型信息整定降阶自抗扰控制器参数的方法
WO2023220641A2 (en) 2022-05-11 2023-11-16 Juno Therapeutics, Inc. Methods and uses related to t cell therapy and production of same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143731A (en) * 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
DE69329792T2 (de) * 1992-10-08 2001-05-31 Supratek Pharma Inc Zusammensetzung von in mizellen eingeschlossenen antineoplastischen wirkstoffen

Also Published As

Publication number Publication date
CN1192678A (zh) 1998-09-09
DE69630615T2 (de) 2004-09-30
JP4167299B2 (ja) 2008-10-15
EP0871432B1 (de) 2003-11-05
US5817321A (en) 1998-10-06
JPH11507619A (ja) 1999-07-06
EP1310244A3 (de) 2004-01-14
NZ313271A (en) 2001-03-30
EP1310244A2 (de) 2003-05-14
DE69630615D1 (de) 2003-12-11
EP0871432A2 (de) 1998-10-21
AU6529796A (en) 1996-12-30
AU700021B2 (en) 1998-12-17
WO1996040055A3 (en) 1997-04-24
CA2222776A1 (en) 1996-12-19
WO1996040055A2 (en) 1996-12-19
BR9609176A (pt) 1999-08-24
RU2166934C2 (ru) 2001-05-20

Similar Documents

Publication Publication Date Title
ATE253352T1 (de) Verwendung einer zusammensetzung enthaltend polyether block copolymere
DE69617042D1 (de) Fluorhaltige, elastische copolymere, härtbare zusammensetzung und daraus hergestellte dichtungsmasse
DE3583560D1 (de) Polymerisationsverfahren und polymerzusammensetzungen.
FI965203A (fi) Morfiinia, polypyrrolidonia ja polyalkyleenioksidia sisältävä koostumus
DE68920529T2 (de) Blockcopolymere und Zusammensetzungen davon.
JPS6445433A (en) Polyarylenesulfide block copolymer, manufacture and use
AU1156688A (en) Wettable, hydrophilic, soft and oxygen permeable copolymer compositions
BR8902244A (pt) Composicao de revestimento aquosa,auto-reticulavel e polimero de vinila
DE59008276D1 (de) Hydrophile, quellfähige Pfropfcopolymerisate, deren Herstellung und Verwendung.
DE3884453D1 (de) Homogene additionscopolymere von ethylen und cycloolefinmonomeren und deren herstellung.
DE3853340D1 (de) Dien-Blockpolymer und Polymerzusammensetzung.
DE69433657D1 (de) Ethylen-Alpha-Olefin Copolymere und daraus hergestellte Formteile
DE3680737D1 (de) Poly(etherimid-carbonat)-blockcopolymere und diese enthaltende polymermischungen.
DE69602178T2 (de) 2-oxo-1,3-dioxolangruppen enthaltende copolymere und daraus hergestellte beschichtungen
DE3850062T2 (de) Fluorierte Polymere und Copolymere enthaltende Perfluorpolyätherblöcke.
DE3587486T2 (de) Imidazolinone enthaltende Polymere und Copolymere.
MY106109A (en) 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions
DE3766276D1 (de) Gegen abblaettern bestaendige polymerzusammensetzung, sowie beschichtung.
DE69025260T2 (de) Silikonpolymere, Copolymere und Blockcopolymere und Verfahren zu deren Herstellung
DE69106805D1 (de) Polyoxyalkylenseitenketten enthaltende Copolymere.
AU6213190A (en) Blends of carbonate polymer, polyacetal and compatibilizer
DE68920777D1 (de) Fluor enthaltende Copolymere, Verfahren zur Herstellung davon und Vernetzungszusammensetzungen.
DE59004277D1 (de) Copolymerisat sowie dessen Verwendung.
ES2044100T3 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
DE69022171T2 (de) Polyacetalkopolymer und zusammensetzungen daraus.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties